Amyloid‐related imaging abnormalities from trials of solanezumab for Alzheimer's disease

Abstract

Asymptomatic ARIA-E was detected in solanezumab-treated and placebo-treated AD patients. ARIA-E occurs infrequently during solanezumab and placebo treatments but may occur repeatedly in some patients.